FABBEU Launches First Skincare Brand For Gen-Z in India

FABBEU Launches First Skincare Brand For Gen-Z in India

The brand aims at providing skincare products to the younger generation based on their skin types

December 29: FABBEU, India’s first Gen-Z skincare brand, provides its products to customers based on their skin types. Launched on December 24, 2021, in Mumbai, the brand uses AI technology to analyze the correct skin type of customers. FABBEU makes sure that the customers get their skin types assessed within a few minutes to obtain skin care products that best suit them. The company allows visitors to get free skin test reports on its official website – www.fabbeu.com.

FABBEU, an acronym for “Fabulous You”, is founded by Ankiit Khemka, a current MBA student at NMIMS and Bhavana Khemka, a B.Pharma student at NMIMS- two young siblings from Mumbai. The foundation of their venture was laid when they were not able to find skincare products that matched their skin types. On realizing that the majority of the country’s youth is facing similar issues, the young duo decided to make Gen-Z skincare easier and more efficient by launching FABBEU and providing dermatologist-tested skin care products to the customers.

Based on their specific skin types, FABBEU provides its customers with a range of skincare products, including Bluelight Protection Cream, Day Cream, and Facewash. It allows the customers to get their skin analyzed and place orders on the brand’s official website.

Ankiit Khemka, the co-founder and COO of FABBEU, believes that technology plays a major role in fulfilling the needs of the Gen-Z audience in the age of digitization. He says, “Technology is at the heart of this generation and is required to bring about changes that matter. After spending several months researching and trying different ingredients on our own skins, we have been successful in developing skincare products that suit different skin types. We believe that the use of an AI-based skin analyzer would cater to the specific skincare needs of the Gen-Z audience.”

“We have prioritized the safety of our customers while providing them with skincare products. All our products are developed using the best possible formulations that are effective yet safe on the skin of the users,” adds Bhavana Khemka, FABBEU’s co-founder.

Accredited by Startup India, FABBEU plans to make its products available on Amazon, Flipkart, and Nykaa soon. To know more about the brand and its products, visit its official Instagram page (@fabbeu_india).


19 thoughts on “FABBEU Launches First Skincare Brand For Gen-Z in India

  1. A later generation of inhibitors were better at blocking the activity of these transporters but were also very toxic in clinical trials adverse effects of tamoxifen A more detailed description of studies in this group and a summary of outcomes can be found in Appendixes H and I

  2. A LASIK should be performed by a LASIK specialist, and you need to be evaluated by a LASIK specialist clomiphene interactions Coates, International Breast Cancer Study Group, Bern, Switzerland, and University of Sydney, Sydney, Australia; Jacek Jassem, Medical University of Gdansk, Gdansk, Poland; Stephen Jones, US Oncology Research, The Woodlands, TX; Per E

  3. Fatal adverse reactions can occur but are rare 1 in 170, 000 cases 10 12, but with 25 million CT contrast studies performed annually in the United States, that equates to 150 deaths in the United States annually best cialis online PMID 17917150 Review

  4. Weight Loss Supplements Even A Minuscule Amount keto low calorie recipes Of This Compound Is Sufficient Sufficient To Reduce Visceral Adipose Tissue Weights And The Induction Of High Lipid Fat Content Material This Is Achieved By Way Of The Inhibition Of Fat Layers On The Periphery Of The Liver, Ensuing In The Reversion Of Leptin Concentration And The Normalization Of Lipid Abnormalities online cialis Among the choices, this is the only agent that must be monitored this closely

  5. In conclusion, we have demonstrated the use of stable CYP2D6 expression cell models in the kinetic assessment of CYP2D6 1 and 10 mediated bufuralol 1 hydroxylation and AMMC O demethylation cialis 10mg t allow ourselves to be down because thatГў

  6. Based on safety data in Table 3, the DOC combined therapies had consistent adverse events AEs in the two selected clinical trials of combined therapies of DOC with CAP and CIS respectively discreet cialis meds Patients who follow doctor s orders and swallow beta blockers have a 28 percent greater risk of suffering from type 2 diabetes due to extreme fat gain

Leave a Reply

Your email address will not be published.